Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$322.93
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Medpace Hldgs Analyst Ratings and Price Targets | NASDAQ:MEDP | Benzinga
Medpace Holdings Inc has a consensus price target of $391.3 based on the ratings of 11 analysts. The high is $480 issued by UBS on March 8, 2024. The low is $336 issued by Deutsche Bank on July 24, 2024. The 3 most-recent analyst ratings were released by Baird, Baird, and TD Cowen on January 27, 2025, November 25, 2024, and October 23, 2024, respectively. With an average price target of $362.67 between Baird, Baird, and TD Cowen, there's an implied 12.31% upside for Medpace Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
TD Cowen
Redburn Atlantic
Truist Securities
UBS
1calculated from analyst ratings
Analyst Ratings for Medpace Hldgs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 01/27/2025 | Buy Now | 12.1% | Baird | Eric Coldwell79% | $354 → $362 | Maintains | Neutral | Get Alert |
| 11/25/2024 | Buy Now | 9.62% | Baird | Eric Coldwell79% | $349 → $354 | Maintains | Neutral | Get Alert |
| 10/23/2024 | Buy Now | 15.2% | TD Cowen | Charles Rhyee37% | $413 → $372 | Maintains | Buy | Get Alert |
| 10/23/2024 | Buy Now | 8.07% | Baird | Eric Coldwell79% | $413 → $349 | Downgrade | Outperform → Neutral | Get Alert |
| 10/22/2024 | Buy Now | — | William Blair | Max Smock23% | — | Reiterates | → Outperform | Get Alert |
| 10/14/2024 | Buy Now | 25.1% | Redburn Atlantic | — | → $404 | Initiates | → Buy | Get Alert |
| 10/14/2024 | Buy Now | 22.94% | Truist Securities | Jailendra Singh37% | $415 → $397 | Maintains | Hold | Get Alert |
| 09/27/2024 | Buy Now | 8.38% | UBS | Dan Leonard55% | $420 → $350 | Downgrade | Buy → Neutral | Get Alert |
| 09/25/2024 | Buy Now | 6.83% | Jefferies | David Windley74% | $415 → $345 | Downgrade | Buy → Hold | Get Alert |
| 09/20/2024 | Buy Now | 27.89% | Baird | Eric Coldwell79% | $430 → $413 | Maintains | Outperform | Get Alert |
| 09/11/2024 | Buy Now | — | William Blair | Max Smock23% | — | Reiterates | → Outperform | Get Alert |
| 08/01/2024 | Buy Now | 28.51% | Truist Securities | Jailendra Singh37% | → $415 | Initiates | → Hold | Get Alert |
| 07/24/2024 | Buy Now | 33.78% | Guggenheim | Sandy Draper72% | $464 → $432 | Maintains | Buy | Get Alert |
| 07/24/2024 | Buy Now | 33.16% | Baird | Eric Coldwell79% | $469 → $430 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | 4.05% | Deutsche Bank | Justin Bowers51% | $395 → $336 | Maintains | Hold | Get Alert |
| 07/24/2024 | Buy Now | 34.39% | TD Cowen | Charles Rhyee37% | $452 → $434 | Maintains | Buy | Get Alert |
| 07/23/2024 | Buy Now | — | William Blair | Max Smock23% | — | Reiterates | → Outperform | Get Alert |
| 07/08/2024 | Buy Now | 45.23% | Baird | Eric Coldwell79% | $456 → $469 | Maintains | Outperform | Get Alert |
| 05/29/2024 | Buy Now | 39.97% | TD Cowen | Charles Rhyee37% | → $452 | Initiates | → Buy | Get Alert |
| 05/28/2024 | Buy Now | 34.7% | Mizuho | Ann Hynes86% | → $435 | Initiates | → Buy | Get Alert |
| 04/24/2024 | Buy Now | 43.68% | Guggenheim | Sandy Draper72% | $453 → $464 | Maintains | Buy | Get Alert |
| 04/24/2024 | Buy Now | 40.59% | Baird | Eric Coldwell79% | $446 → $454 | Maintains | Outperform | Get Alert |
| 04/23/2024 | Buy Now | 39.35% | Jefferies | David Windley74% | $340 → $450 | Upgrade | Hold → Buy | Get Alert |
| 03/18/2024 | Buy Now | 22.32% | Deutsche Bank | Justin Bowers51% | → $395 | Initiates | → Hold | Get Alert |
| 03/08/2024 | Buy Now | 48.64% | UBS | John Sourbeer30% | $452 → $480 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 39.97% | UBS | John Sourbeer30% | $282 → $452 | Upgrade | Neutral → Buy | Get Alert |
| 02/14/2024 | Buy Now | 26.34% | Baird | Eric Coldwell79% | $312 → $408 | Maintains | Outperform | Get Alert |
| 01/17/2024 | Buy Now | -3.38% | Baird | Eric Coldwell79% | $302 → $312 | Maintains | Outperform | Get Alert |
| 10/24/2023 | Buy Now | -10.51% | Baird | Eric Coldwell79% | $270 → $289 | Upgrade | Neutral → Outperform | Get Alert |
| 07/25/2023 | Buy Now | -15.46% | Guggenheim | Sandy Draper72% | $252 → $273 | Maintains | Buy | Get Alert |
| 05/08/2023 | Buy Now | -21.96% | Guggenheim | Sandy Draper72% | → $252 | Upgrade | Neutral → Buy | Get Alert |
| 02/15/2023 | Buy Now | -27.85% | Baird | Eric Coldwell79% | $226 → $233 | Maintains | Neutral | Get Alert |
| 10/27/2022 | Buy Now | — | UBS | John Sourbeer30% | — | Upgrade | Sell → Neutral | Get Alert |
| 10/26/2022 | Buy Now | -32.8% | Baird | Eric Coldwell79% | $200 → $217 | Maintains | Neutral | Get Alert |
| 09/07/2022 | Buy Now | -56.03% | UBS | John Sourbeer30% | → $142 | Initiates | → Sell | Get Alert |
| 05/24/2022 | Buy Now | — | Guggenheim | Sandy Draper72% | — | Initiates | → Neutral | Get Alert |
FAQ
What is the target price for Medpace Hldgs (MEDP) stock?
The latest price target for Medpace Hldgs (NASDAQ:MEDP) was reported by Baird on January 27, 2025. The analyst firm set a price target for $362.00 expecting MEDP to rise to within 12 months (a possible 12.10% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Medpace Hldgs (MEDP)?
The latest analyst rating for Medpace Hldgs (NASDAQ:MEDP) was provided by Baird, and Medpace Hldgs maintained their neutral rating.
When was the last upgrade for Medpace Hldgs (MEDP)?
The last upgrade for Medpace Holdings Inc happened on April 23, 2024 when Jefferies raised their price target to $450. Jefferies previously had a hold for Medpace Holdings Inc.
When was the last downgrade for Medpace Hldgs (MEDP)?
The last downgrade for Medpace Holdings Inc happened on October 23, 2024 when Baird changed their price target from $413 to $349 for Medpace Holdings Inc.
When is the next analyst rating going to be posted or updated for Medpace Hldgs (MEDP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medpace Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medpace Hldgs was filed on January 27, 2025 so you should expect the next rating to be made available sometime around January 27, 2026.
Is the Analyst Rating Medpace Hldgs (MEDP) correct?
While ratings are subjective and will change, the latest Medpace Hldgs (MEDP) rating was a maintained with a price target of $354.00 to $362.00. The current price Medpace Hldgs (MEDP) is trading at is $322.93, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.